P2RY13阳性肿瘤相关巨噬细胞促进中性粒细胞凋亡(NETosis),并与多种癌症的不良预后相关。
P2RY13-Negative Tumor-Associated Macrophages Promote NETosis and Are Associated with Poor Prognosis Across Multiple Cancers
Shen Yang, Guangsheng Zhu, Zixuan Hu, Mingbiao Li, Jianfang Wang, Zhanrui Zhang, Jun Chen, Renwang Liu
Journal:Cancers
IF:4.8
DOI:10.3390/cancers18152500
PMID:
Published:2026-08-04
research field:生物医学工程材料科学
Abstract
Simple SummaryNeutrophil extracellular traps (NETs) promote tumor progression, yet the mechanisms underlying NET formation (NETosis) within the tumor immune microenvironment remain incompletely understood. Low P2RY13 expression has been linked to pro-tumor neutrophils in lung adenocarcinoma. In this study, pan-cancer bioinformatics analyses showed that reduced P2RY13 expression is commonly associated with poor prognosis. Single-cell and tissue microarray analyses further suggested that P2RY13-negative tumor-associated macrophages (TAMs) are highly enriched in tumor tissues in multiple cancers, including lung adenocarcinoma, liver hepatocellular carcinoma, and colorectal cancer. Increased infiltration of these TAMs was associated with enhanced NET formation. In vitro experiments further confirmed that P2RY13-silenced TAM-like macrophages induce neutrophil NETosis. These findings suggest a potential mechanism by which P2RY13-negative TAMs promote NET formation and contribute to adverse clinical outcomes, providing potential therapeutic insights.Background: Neutrophil extracellular traps (NETs) promote tumor progression and immune evasion across multiple cancers. However, the mechanisms governing NET formation (NETosis) within the tumor immune microenvironment remain incompletely understood. Low P2RY13 expression is associated with the pro-tumor activity of neutrophils in lung adenocarcinoma.Methods: Pan-cancer bioinformatics analyses were performed, including differential gene expression, prognostic, tumor-infiltrating immune cell, and NET scoring analyses. Single-cell profiling was conducted using the Tumor Immune Single-cell Hub 2 database. Immunohistochemical (IHC) and multiplex immunofluorescence (mIF) staining of tissue microarrays (TMAs) was performed to validate findings in lung adenocarcinoma (LUAD), liver hepatocellular carcinoma (LIHC), and colorectal cancer (CRC). In vitro validation was conducted using gene modulation, tumor-cell-conditioned medium (CM) e
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


